Our results showed a suppression (1.6 fold, p<0.01) of ZSCAN4 expression in response to 3-AB treatment in the FSHD myoblasts (Figure 2B). The gene discussed is ZSCAN4; the disease is facioscapulohumeral muscular dystrophy.